326 related articles for article (PubMed ID: 34174977)
1. Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
Farooqi AA; Attar R; Tanriover G; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):47-51. PubMed ID: 34174977
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
[TBL] [Abstract][Full Text] [Related]
3. Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases.
Luo D; Liu F; Zhang J; Shao Q; Tao W; Xiao R; Dai W; Qian K
Mol Immunol; 2021 Mar; 131():191-200. PubMed ID: 33446392
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.
Al-Hawary SIS; Jasim SA; Romero-Parra RM; Bustani GS; Hjazi A; Alghamdi MI; Kareem AK; Alwaily ER; Zabibah RS; Gupta J; Mahmoudi R; Hosseini-Fard S
Pathol Res Pract; 2023 Jun; 246():154490. PubMed ID: 37141699
[TBL] [Abstract][Full Text] [Related]
5. The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome.
Menon MP; Hua KF
Front Immunol; 2020; 11():569524. PubMed ID: 33101288
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as important regulators of the NLRP3 inflammasome.
Zamani P; Oskuee RK; Atkin SL; Navashenaq JG; Sahebkar A
Prog Biophys Mol Biol; 2020 Jan; 150():50-61. PubMed ID: 31100298
[TBL] [Abstract][Full Text] [Related]
7. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
Liao H; Zhang S; Qiao J
Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
9. The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson's disease.
Li Y; Yu C; Jiang X; Fu J; Sun N; Zhang D
Pathol Res Pract; 2024 Jun; 258():155349. PubMed ID: 38772115
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
11. LncRNA Gm14205 induces astrocytic NLRP3 inflammasome activation via inhibiting oxytocin receptor in postpartum depression.
Zhu J; Tang J
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32706026
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis.
Hu J; Wu H; Wang D; Yang Z; Dong J
Biochimie; 2019 Feb; 157():102-110. PubMed ID: 30347231
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
[TBL] [Abstract][Full Text] [Related]
14. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into the interplay between m
Yi YC; Chen XY; Zhang J; Zhu JS
Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Kisspeptin mediated signaling by non-coding RNAs in different cancers: the beginning of a new era.
Farooqi AA; Attar R; Bageshlooyafshar B; Sabitaliyevich UY; Nurmurzayevich SB; Yelekenova AB; Gormus U
Cell Mol Biol (Noisy-le-grand); 2019 Mar; 65(3):72-75. PubMed ID: 30942167
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
19. Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation.
Ge Q; Chen X; Zhao Y; Mu H; Zhang J
Life Sci; 2021 Feb; 267():118918. PubMed ID: 33352170
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ENSMUST00000197208 promotes a shift in the Th17/Treg ratio via the P2X7R-NLRP3 inflammasome axis in collagen-induced arthritis.
Pan Y; Wu Y; Liu Y; Wang P; Huang H; Jin J; Fang Y; Huang S; Fan Z; Yu H
Immunol Res; 2024 Apr; 72(2):347-360. PubMed ID: 38066380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
